METHODS: Venous blood samples from 46 pathologically confirmed PDAC patients were collected prospectively before surgery and immunoassayed using a specially designed TU-chip™. Captured CTCs were differentiated into epithelial (E), mesenchymal and hybrid (H) phenotypes. A further 45 non-neoplastic healthy donors provided blood for cell line validation study and CTC false positive quantification.
FINDINGS: A validated multivariable model consisting of disjunctively combined CTC phenotypes: "H-CTC≥15.0 CTCs/2ml OR E-CTC≥11.0 CTCs/2ml" generated an optimal prediction of metastasis with a sensitivity of 1.000 (95% CI 0.889-1.000) and specificity of 0.886 (95% CI 0.765-0.972). The adjusted Kaplan-Meier median OS constructed using Cox proportional-hazard models and stratified for E-CTC
MATERIALS AND METHODS: In this study we analysed the clinical and pathological features of 32 Taiwanese MDS patients with del(5q) (ie, del(5q) alone [Group A, n = 11], del(5q) with one additional cytogenetic abnormality other than monosomy 7 or del(7q) [Group B, del(5q)+1; n = 6], and del(5q) with ≥2 additional cytogenetic abnormalities [Group C, n = 15]).
RESULTS: Progression-free survival (PFS) and overall survival (OS) were more favourable for Group A than for Groups B (p < 0.05) and C (p ≤ 0.001). Multivariate analysis showed that age >70 years, thrombocytopenia, and karyotype other than del(5q) alone were poor prognostic factors. Among the patients that had World Health Organization (WHO)-defined MDS with isolated del(5q), one patient (9%) had a typical marrow morphology of 5q minus syndrome with erythroid hypoplasia and four patients (36%) had hypolobated megakaryocytes. In addition, PFS and OS were significantly more favorable for the patients with del(5q) alone than for those with del(5q)+1 (p < 0.05).
CONCLUSION: The bone marrow morphology, clinical features, and prognosis of Taiwanese MDS patients with del(5q) were different from those associated with MDS with isolated del(5q) as defined in the current WHO classification. Researchers should compare different geographic regions and racial populations to determine whether geographic and racial differences exist with respect to MDS with del(5q).
EVIDENCE ACQUISITION: This study was based on PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyzes) statement guidelines for a systematic review of the academic databases Scopus, Web of Science, PubMed, EBSCOhost (SportDiscus), and Google Scholar. The PEDro scale was used to assess the methodological quality of the included publications, which ranged from moderate to high quality. The systematic review protocol was registered on inplasy.com (INPLASY202380049).
EVIDENCE SYNTHESIS: Out of 249 studies identified, 93 articles were evaluated as eligible, and after the screening, 18 studies were finally included in this systematic review. Meta-analysis results showed a significant enhancement on vertical jump height in the BFRT group compared to the control group (SMD=1.39, 95% CI=0.30-2.49, P=0.01). BFRT was able to significantly increase maximal oxygen uptake (SMD=1.65, 95% CI=0.56-2.74, P<0.01). While no significant improvement in sprint time was observed (SMD= -0.18, 95% CI=-1.18-0.82, P=0.115).
CONCLUSIONS: The finding suggests that BFRT is beneficial to athletes as this training method can be effective in enhancing physical and technical performance in athletes. Nevertheless, further analysis needs to be conducted to fully determine the effectiveness of the moderators of the intervention on sports performance.